by Team Small News | Nov 9, 2025 | Pharma, Zydus
Zydus Lifesciences Limited, an Indian pharmaceutical company, has received tentative approval from the United States Food and Drug Administration (USFDA) for its Olaparib Tablets, 100 mg and 150 mg. This medication is used to treat certain types of ovarian, breast,...
by Team Small News | Nov 8, 2025 | Pharma, Piramal Pharma
Motilal Oswal has maintained a “buy” rating on Piramal Pharma despite the company facing near-term headwinds. The brokerage firm reviewed Piramal Pharma’s Q2 results and noted that the company’s performance was impacted by one-time items and... by Team Small News | Nov 8, 2025 | Lupin, Pharma
The Lupin Bioresearch Center, a prominent research facility, has achieved a significant milestone by receiving zero observations from the United States Food and Drug Administration (USFDA) following a successful inspection and assessment. This impressive feat... by Team Small News | Nov 8, 2025 | Cipla, Pharma
Eli Lilly’s diabetes medication, Mounjaro, has achieved unprecedented success in India’s pharmaceutical market, crossing ₹1 billion in monthly sales. This remarkable feat is a result of the company’s strategic partnership with Cipla, a leading Indian...
by Team Small News | Nov 8, 2025 | Pharma, Sun Pharma
Sun Pharmaceutical Industries Ltd. has reported a significant shift in its business mix, with innovative medicines outpacing generic drug sales in the United States during the second quarter of fiscal year 2026. The company’s innovative medicines, including... by Team Small News | Nov 7, 2025 | Aurobindo Pharma, Pharma
Aurobindo Pharma, a leading pharmaceutical company, has released its consolidated financial results for the quarter ended September 2025. The company’s net sales for the quarter stood at Rs 8,285.70 crore, representing a year-over-year (Y-o-Y) growth of 6.28%....